Status | Study |
Completed |
Study Name: A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C Condition: Niemann-Pick Disease, Type C Date: 2015-04-22 |
Recruiting |
Study Name: Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects Condition: Familial Frontotemporal Dementia Date: 2015-02-20 |
Completed |
Study Name: Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1 Condition: Neimann-Pick Disease Date: 2014-04-25 Interventions: Drug: Vorinostat Histone deactylase inhibitor |
Recruiting |
Study Name: Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia Condition: Frontotemporal Dementia Date: 2013-09-03 Interventions: Drug: Intranasal oxytocin Oxyt |
Completed |
Study Name: Longitudinal Study of Cognition With Niemann-Pick Disease, Type C Condition: Niemann-Pick Disease, Type C Date: 2013-07-04 |
Completed |
Study Name: Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. Condition: Alzheimer's Disease Frontotemporal Dementia Date: 2013-06-27 Interventions: Drug: florbetapir 18F Subjects |
Completed |
Study Name: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) Condition: Behavioral Variant Frontotemporal Dementia (bvFTD) Date: 2012-06-20 Interventions: Drug: TRx0237 TRx0237 100 mg t |
Completed |
Study Name: Safety Study of Intranasal Oxytocin in Frontotemporal Dementia Condition: Frontotemporal Dementia Date: 2011-06-29 Interventions: Drug: oxytocin Patients will b |
Completed |
Study Name: Oxytocin and Social Cognition in Frontotemporal Dementia Condition: Frontotemporal Dementia Pick's Disease Date: 2009-10-23 Interventions: Drug: intranasal oxytocin Participants will receive 24 IU of oxytocin or placebo (Salinex saline nasal s |
Completed |
Study Name: Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine Condition: Niemann-Pick Disease, Type C Date: 2009-09-10 Interventions: Drug: N-Acetyl Cysteine 900mg effervescent tablet; Dosed as 15 mg/kg/day (maximum dose 900 mg per day) f |